nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirabegron—ADRB3—polycystic ovary syndrome	0.876	1	CbGaD
Mirabegron—Arbutamine—ADRB3—polycystic ovary syndrome	0.00299	0.424	CrCbGaD
Mirabegron—Labetalol—ADRB3—polycystic ovary syndrome	0.00212	0.301	CrCbGaD
Mirabegron—ADRB3—adipose tissue—polycystic ovary syndrome	0.00125	0.112	CbGeAlD
Mirabegron—Arbutamine—ADRB2—polycystic ovary syndrome	0.00114	0.161	CrCbGaD
Mirabegron—CYP3A4—urine—polycystic ovary syndrome	0.00113	0.101	CbGeAlD
Mirabegron—CYP2D6—urine—polycystic ovary syndrome	0.00111	0.0996	CbGeAlD
Mirabegron—ADRB3—female gonad—polycystic ovary syndrome	0.00104	0.0933	CbGeAlD
Mirabegron—Labetalol—ADRB2—polycystic ovary syndrome	0.000807	0.114	CrCbGaD
Mirabegron—ORM1—endometrium—polycystic ovary syndrome	0.000641	0.0574	CbGeAlD
Mirabegron—Breast disorder—Metformin—polycystic ovary syndrome	0.000517	0.0515	CcSEcCtD
Mirabegron—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.000512	0.051	CcSEcCtD
Mirabegron—Abdominal distension—Metformin—polycystic ovary syndrome	0.000498	0.0496	CcSEcCtD
Mirabegron—Influenza—Metformin—polycystic ovary syndrome	0.000495	0.0493	CcSEcCtD
Mirabegron—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00046	0.0458	CcSEcCtD
Mirabegron—ALB—adrenal gland—polycystic ovary syndrome	0.000455	0.0407	CbGeAlD
Mirabegron—ORM1—endocrine gland—polycystic ovary syndrome	0.00045	0.0402	CbGeAlD
Mirabegron—Infestation—Metformin—polycystic ovary syndrome	0.000441	0.0439	CcSEcCtD
Mirabegron—Infestation NOS—Metformin—polycystic ovary syndrome	0.000441	0.0439	CcSEcCtD
Mirabegron—BCHE—endometrium—polycystic ovary syndrome	0.000398	0.0356	CbGeAlD
Mirabegron—Rhinitis—Metformin—polycystic ovary syndrome	0.000397	0.0395	CcSEcCtD
Mirabegron—SLCO1A2—endocrine gland—polycystic ovary syndrome	0.000396	0.0355	CbGeAlD
Mirabegron—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.000389	0.0388	CcSEcCtD
Mirabegron—Eye disorder—Metformin—polycystic ovary syndrome	0.00037	0.0369	CcSEcCtD
Mirabegron—Cardiac disorder—Metformin—polycystic ovary syndrome	0.000368	0.0366	CcSEcCtD
Mirabegron—BCHE—uterus—polycystic ovary syndrome	0.000366	0.0328	CbGeAlD
Mirabegron—BCHE—pituitary gland—polycystic ovary syndrome	0.00036	0.0322	CbGeAlD
Mirabegron—BCHE—adipose tissue—polycystic ovary syndrome	0.000358	0.0321	CbGeAlD
Mirabegron—Vision blurred—Metformin—polycystic ovary syndrome	0.000325	0.0324	CcSEcCtD
Mirabegron—BCHE—adrenal gland—polycystic ovary syndrome	0.000321	0.0288	CbGeAlD
Mirabegron—Palpitations—Metformin—polycystic ovary syndrome	0.000305	0.0303	CcSEcCtD
Mirabegron—BCHE—vagina—polycystic ovary syndrome	0.000298	0.0266	CbGeAlD
Mirabegron—Hypertension—Metformin—polycystic ovary syndrome	0.000298	0.0296	CcSEcCtD
Mirabegron—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000291	0.029	CcSEcCtD
Mirabegron—Infection—Metformin—polycystic ovary syndrome	0.00028	0.0278	CcSEcCtD
Mirabegron—BCHE—endocrine gland—polycystic ovary syndrome	0.000279	0.0249	CbGeAlD
Mirabegron—Skin disorder—Metformin—polycystic ovary syndrome	0.000273	0.0272	CcSEcCtD
Mirabegron—ABCB1—embryo—polycystic ovary syndrome	0.000259	0.0232	CbGeAlD
Mirabegron—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000256	0.0255	CcSEcCtD
Mirabegron—Dyspepsia—Metformin—polycystic ovary syndrome	0.000248	0.0247	CcSEcCtD
Mirabegron—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000243	0.0242	CcSEcCtD
Mirabegron—Fatigue—Metformin—polycystic ovary syndrome	0.000243	0.0242	CcSEcCtD
Mirabegron—Constipation—Metformin—polycystic ovary syndrome	0.000241	0.024	CcSEcCtD
Mirabegron—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00023	0.0229	CcSEcCtD
Mirabegron—Urticaria—Metformin—polycystic ovary syndrome	0.000224	0.0223	CcSEcCtD
Mirabegron—Abdominal pain—Metformin—polycystic ovary syndrome	0.000222	0.0221	CcSEcCtD
Mirabegron—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000212	0.019	CbGeAlD
Mirabegron—Asthenia—Metformin—polycystic ovary syndrome	0.000202	0.0201	CcSEcCtD
Mirabegron—Pruritus—Metformin—polycystic ovary syndrome	0.000199	0.0198	CcSEcCtD
Mirabegron—CYP2D6—female gonad—polycystic ovary syndrome	0.000199	0.0178	CbGeAlD
Mirabegron—Diarrhoea—Metformin—polycystic ovary syndrome	0.000193	0.0192	CcSEcCtD
Mirabegron—ABCB1—endometrium—polycystic ovary syndrome	0.000189	0.017	CbGeAlD
Mirabegron—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000188	0.0168	CbGeAlD
Mirabegron—Dizziness—Metformin—polycystic ovary syndrome	0.000186	0.0185	CcSEcCtD
Mirabegron—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000185	0.0165	CbGeAlD
Mirabegron—Rash—Metformin—polycystic ovary syndrome	0.000177	0.0177	CcSEcCtD
Mirabegron—Dermatitis—Metformin—polycystic ovary syndrome	0.000177	0.0176	CcSEcCtD
Mirabegron—Headache—Metformin—polycystic ovary syndrome	0.000176	0.0176	CcSEcCtD
Mirabegron—ABCB1—uterus—polycystic ovary syndrome	0.000175	0.0156	CbGeAlD
Mirabegron—ABCB1—pituitary gland—polycystic ovary syndrome	0.000171	0.0153	CbGeAlD
Mirabegron—ABCB1—adipose tissue—polycystic ovary syndrome	0.000171	0.0153	CbGeAlD
Mirabegron—Nausea—Metformin—polycystic ovary syndrome	0.000167	0.0166	CcSEcCtD
Mirabegron—ABCB1—adrenal gland—polycystic ovary syndrome	0.000153	0.0137	CbGeAlD
Mirabegron—ABCB1—female gonad—polycystic ovary syndrome	0.000143	0.0128	CbGeAlD
Mirabegron—ABCB1—vagina—polycystic ovary syndrome	0.000142	0.0127	CbGeAlD
Mirabegron—ABCB1—endocrine gland—polycystic ovary syndrome	0.000133	0.0119	CbGeAlD
Mirabegron—ADRB3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.56e-05	0.00048	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	4.52e-05	0.000476	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—FGF18—polycystic ovary syndrome	4.49e-05	0.000472	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—RBP4—polycystic ovary syndrome	4.45e-05	0.000468	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—HMMR—polycystic ovary syndrome	4.44e-05	0.000467	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	4.43e-05	0.000467	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—LHB—polycystic ovary syndrome	4.4e-05	0.000463	CbGpPWpGaD
Mirabegron—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	4.4e-05	0.000463	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.38e-05	0.000461	CbGpPWpGaD
Mirabegron—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	4.36e-05	0.000459	CbGpPWpGaD
Mirabegron—ALB—Metabolism—ISYNA1—polycystic ovary syndrome	4.3e-05	0.000453	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—HSD3B2—polycystic ovary syndrome	4.3e-05	0.000453	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—HSD3B1—polycystic ovary syndrome	4.23e-05	0.000446	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	4.21e-05	0.000443	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	4.19e-05	0.00044	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	4.18e-05	0.00044	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—AKR1C1—polycystic ovary syndrome	4.17e-05	0.000438	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—YAP1—polycystic ovary syndrome	4.15e-05	0.000437	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—GAB1—polycystic ovary syndrome	4.1e-05	0.000431	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	4.06e-05	0.000427	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	4.06e-05	0.000427	CbGpPWpGaD
Mirabegron—ALB—Folate Metabolism—IL6—polycystic ovary syndrome	4.01e-05	0.000422	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	3.97e-05	0.000417	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	3.93e-05	0.000413	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—INSR—polycystic ovary syndrome	3.92e-05	0.000412	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—LHB—polycystic ovary syndrome	3.86e-05	0.000406	CbGpPWpGaD
Mirabegron—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	3.85e-05	0.000405	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—SULT2A1—polycystic ovary syndrome	3.83e-05	0.000403	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	3.82e-05	0.000402	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	3.82e-05	0.000402	CbGpPWpGaD
Mirabegron—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	3.8e-05	0.0004	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—HSD3B2—polycystic ovary syndrome	3.77e-05	0.000397	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	3.77e-05	0.000397	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	3.73e-05	0.000392	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.72e-05	0.000391	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—RRM2—polycystic ovary syndrome	3.71e-05	0.000391	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.66e-05	0.000385	CbGpPWpGaD
Mirabegron—ALB—Metabolism—TEAD2—polycystic ovary syndrome	3.66e-05	0.000385	CbGpPWpGaD
Mirabegron—ALB—Metabolism—AKR1C2—polycystic ovary syndrome	3.66e-05	0.000385	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—AKR1C1—polycystic ovary syndrome	3.65e-05	0.000385	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PGR—polycystic ovary syndrome	3.63e-05	0.000382	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—YAP1—polycystic ovary syndrome	3.58e-05	0.000377	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	3.55e-05	0.000374	CbGpPWpGaD
Mirabegron—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	3.54e-05	0.000373	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	3.52e-05	0.00037	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—PLAT—polycystic ovary syndrome	3.5e-05	0.000368	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	3.46e-05	0.000364	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—NAMPT—polycystic ovary syndrome	3.44e-05	0.000362	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.42e-05	0.00036	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CYP11A1—polycystic ovary syndrome	3.4e-05	0.000357	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	3.38e-05	0.000355	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	3.37e-05	0.000355	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.37e-05	0.000355	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—GHRL—polycystic ovary syndrome	3.37e-05	0.000355	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PLAT—polycystic ovary syndrome	3.37e-05	0.000355	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—SULT2A1—polycystic ovary syndrome	3.36e-05	0.000354	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	3.32e-05	0.00035	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	3.26e-05	0.000343	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—RRM2—polycystic ovary syndrome	3.26e-05	0.000343	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.25e-05	0.000342	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—ATF1—polycystic ovary syndrome	3.22e-05	0.000338	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—AKR1C3—polycystic ovary syndrome	3.21e-05	0.000337	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	3.21e-05	0.000337	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	3.21e-05	0.000337	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	3.21e-05	0.000337	CbGpPWpGaD
Mirabegron—ALB—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	3.19e-05	0.000335	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CYP17A1—polycystic ovary syndrome	3.16e-05	0.000332	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—YAP1—polycystic ovary syndrome	3.14e-05	0.00033	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.14e-05	0.00033	CbGpPWpGaD
Mirabegron—ADRB3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	3.12e-05	0.000328	CbGpPWpGaD
Mirabegron—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	3.11e-05	0.000327	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PNPLA2—polycystic ovary syndrome	3.07e-05	0.000323	CbGpPWpGaD
Mirabegron—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	3.06e-05	0.000322	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	3.03e-05	0.000319	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	3.02e-05	0.000318	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	3.02e-05	0.000318	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—NAMPT—polycystic ovary syndrome	3.02e-05	0.000317	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3e-05	0.000316	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CYP11A1—polycystic ovary syndrome	2.98e-05	0.000314	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—LEP—polycystic ovary syndrome	2.98e-05	0.000313	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NGFR—polycystic ovary syndrome	2.97e-05	0.000312	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	2.96e-05	0.000311	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—POMC—polycystic ovary syndrome	2.95e-05	0.00031	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—PRL—polycystic ovary syndrome	2.94e-05	0.000309	CbGpPWpGaD
Mirabegron—ALB—Metabolism—SRD5A1—polycystic ovary syndrome	2.91e-05	0.000306	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	2.9e-05	0.000305	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	2.86e-05	0.000301	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.83e-05	0.000298	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—AKR1C3—polycystic ovary syndrome	2.81e-05	0.000296	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.79e-05	0.000294	CbGpPWpGaD
Mirabegron—ALB—Metabolism—STAR—polycystic ovary syndrome	2.77e-05	0.000292	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	2.77e-05	0.000292	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CYP17A1—polycystic ovary syndrome	2.77e-05	0.000291	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.74e-05	0.000288	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	2.73e-05	0.000287	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—TH—polycystic ovary syndrome	2.73e-05	0.000287	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—GNAS—polycystic ovary syndrome	2.69e-05	0.000283	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	2.69e-05	0.000283	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—SLC2A4—polycystic ovary syndrome	2.66e-05	0.00028	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	2.66e-05	0.000279	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—GNAS—polycystic ovary syndrome	2.59e-05	0.000272	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—POMC—polycystic ovary syndrome	2.56e-05	0.000269	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	2.55e-05	0.000268	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—INS—polycystic ovary syndrome	2.54e-05	0.000267	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	2.53e-05	0.000266	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	2.5e-05	0.000263	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	2.5e-05	0.000263	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CYP19A1—polycystic ovary syndrome	2.5e-05	0.000263	CbGpPWpGaD
Mirabegron—ALB—Metabolism—HMMR—polycystic ovary syndrome	2.47e-05	0.00026	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.46e-05	0.000259	CbGpPWpGaD
Mirabegron—BCHE—Metabolism of proteins—IGF1—polycystic ovary syndrome	2.46e-05	0.000259	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—STAR—polycystic ovary syndrome	2.43e-05	0.000256	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	2.43e-05	0.000256	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—NRG1—polycystic ovary syndrome	2.42e-05	0.000255	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	2.4e-05	0.000253	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—TH—polycystic ovary syndrome	2.4e-05	0.000252	CbGpPWpGaD
Mirabegron—ALB—Metabolism—HSD3B1—polycystic ovary syndrome	2.36e-05	0.000248	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—SLC2A4—polycystic ovary syndrome	2.33e-05	0.000245	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.33e-05	0.000245	CbGpPWpGaD
Mirabegron—ALB—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.33e-05	0.000245	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	2.32e-05	0.000244	CbGpPWpGaD
Mirabegron—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	2.32e-05	0.000244	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	2.29e-05	0.000241	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—GNAS—polycystic ovary syndrome	2.23e-05	0.000235	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.21e-05	0.000232	CbGpPWpGaD
Mirabegron—ALB—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	2.21e-05	0.000232	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CYP19A1—polycystic ovary syndrome	2.19e-05	0.000231	CbGpPWpGaD
Mirabegron—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	2.17e-05	0.000229	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	2.17e-05	0.000228	CbGpPWpGaD
Mirabegron—ALB—Metabolism—LHB—polycystic ovary syndrome	2.15e-05	0.000226	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—NCOR1—polycystic ovary syndrome	2.12e-05	0.000224	CbGpPWpGaD
Mirabegron—ALB—Metabolism—HSD3B2—polycystic ovary syndrome	2.1e-05	0.000221	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IRS2—polycystic ovary syndrome	2.07e-05	0.000218	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	2.07e-05	0.000217	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	2.04e-05	0.000215	CbGpPWpGaD
Mirabegron—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.04e-05	0.000214	CbGpPWpGaD
Mirabegron—ALB—Metabolism—AKR1C1—polycystic ovary syndrome	2.04e-05	0.000214	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—LEP—polycystic ovary syndrome	2.03e-05	0.000213	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—CYP1A1—polycystic ovary syndrome	2.01e-05	0.000212	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	1.98e-05	0.000208	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	1.98e-05	0.000208	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—GNAS—polycystic ovary syndrome	1.96e-05	0.000206	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	1.95e-05	0.000205	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—LHB—polycystic ovary syndrome	1.88e-05	0.000198	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—MTHFR—polycystic ovary syndrome	1.88e-05	0.000198	CbGpPWpGaD
Mirabegron—ALB—Metabolism—SULT2A1—polycystic ovary syndrome	1.87e-05	0.000197	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—NCOR1—polycystic ovary syndrome	1.86e-05	0.000196	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	1.84e-05	0.000194	CbGpPWpGaD
Mirabegron—ALB—Metabolism—RRM2—polycystic ovary syndrome	1.81e-05	0.000191	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IRS1—polycystic ovary syndrome	1.81e-05	0.00019	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	1.78e-05	0.000188	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	1.78e-05	0.000187	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—CYP1A1—polycystic ovary syndrome	1.77e-05	0.000186	CbGpPWpGaD
Mirabegron—ALB—Metabolism—YAP1—polycystic ovary syndrome	1.75e-05	0.000184	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—POMC—polycystic ovary syndrome	1.74e-05	0.000183	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—IGF1—polycystic ovary syndrome	1.74e-05	0.000183	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—AKT2—polycystic ovary syndrome	1.74e-05	0.000183	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	1.74e-05	0.000183	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—INS—polycystic ovary syndrome	1.73e-05	0.000182	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	1.68e-05	0.000177	CbGpPWpGaD
Mirabegron—ALB—Metabolism—NAMPT—polycystic ovary syndrome	1.68e-05	0.000177	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IGF1—polycystic ovary syndrome	1.68e-05	0.000176	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—AKT2—polycystic ovary syndrome	1.67e-05	0.000176	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.67e-05	0.000176	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP11A1—polycystic ovary syndrome	1.66e-05	0.000175	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	1.66e-05	0.000174	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—SERPINE1—polycystic ovary syndrome	1.65e-05	0.000174	CbGpPWpGaD
Mirabegron—ALB—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.65e-05	0.000173	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—MTHFR—polycystic ovary syndrome	1.65e-05	0.000173	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	1.64e-05	0.000173	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.59e-05	0.000167	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	1.59e-05	0.000167	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	1.57e-05	0.000165	CbGpPWpGaD
Mirabegron—ALB—Metabolism—AKR1C3—polycystic ovary syndrome	1.57e-05	0.000165	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	1.55e-05	0.000163	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP17A1—polycystic ovary syndrome	1.54e-05	0.000162	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	1.53e-05	0.000161	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—PPARG—polycystic ovary syndrome	1.52e-05	0.00016	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—POMC—polycystic ovary syndrome	1.5e-05	0.000158	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	1.5e-05	0.000158	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	1.5e-05	0.000158	CbGpPWpGaD
Mirabegron—SLCO1A2—Metabolism—INS—polycystic ovary syndrome	1.49e-05	0.000157	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	1.47e-05	0.000155	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	1.45e-05	0.000153	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	1.44e-05	0.000152	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	1.39e-05	0.000146	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	1.37e-05	0.000144	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	1.37e-05	0.000144	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	1.35e-05	0.000142	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—PPARG—polycystic ovary syndrome	1.34e-05	0.000141	CbGpPWpGaD
Mirabegron—ALB—Metabolism—TH—polycystic ovary syndrome	1.33e-05	0.00014	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	1.33e-05	0.00014	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—POMC—polycystic ovary syndrome	1.32e-05	0.000139	CbGpPWpGaD
Mirabegron—BCHE—Metabolism—INS—polycystic ovary syndrome	1.31e-05	0.000138	CbGpPWpGaD
Mirabegron—ALB—Metabolism—SLC2A4—polycystic ovary syndrome	1.3e-05	0.000137	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	1.29e-05	0.000136	CbGpPWpGaD
Mirabegron—ADRB3—Signaling by GPCR—IL6—polycystic ovary syndrome	1.28e-05	0.000135	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	1.27e-05	0.000134	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	1.27e-05	0.000134	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	1.22e-05	0.000128	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—TH—polycystic ovary syndrome	1.17e-05	0.000123	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.16e-05	0.000122	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	1.14e-05	0.00012	CbGpPWpGaD
Mirabegron—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	1.14e-05	0.00012	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.13e-05	0.000119	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—TH—polycystic ovary syndrome	1.1e-05	0.000116	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.1e-05	0.000116	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.09e-05	0.000115	CbGpPWpGaD
Mirabegron—ALB—Metabolism—GNAS—polycystic ovary syndrome	1.09e-05	0.000115	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	1.07e-05	0.000113	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	1.07e-05	0.000113	CbGpPWpGaD
Mirabegron—ALB—Metabolism—NCOR1—polycystic ovary syndrome	1.04e-05	0.000109	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1.01e-05	0.000106	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	1.01e-05	0.000106	CbGpPWpGaD
Mirabegron—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	9.84e-06	0.000104	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	9.79e-06	0.000103	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	9.55e-06	0.0001	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	9.44e-06	9.93e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—MTHFR—polycystic ovary syndrome	9.17e-06	9.65e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	9.09e-06	9.57e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	9.07e-06	9.54e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	9e-06	9.47e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	8.96e-06	9.42e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	8.62e-06	9.07e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	8.57e-06	9.02e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	8.46e-06	8.9e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	8.33e-06	8.76e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	8.12e-06	8.55e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	8.04e-06	8.46e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	7.57e-06	7.97e-05	CbGpPWpGaD
Mirabegron—ADRB3—Signaling Pathways—IL6—polycystic ovary syndrome	7.57e-06	7.96e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—PPARG—polycystic ovary syndrome	7.44e-06	7.83e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—POMC—polycystic ovary syndrome	7.34e-06	7.72e-05	CbGpPWpGaD
Mirabegron—ALB—Metabolism—INS—polycystic ovary syndrome	7.3e-06	7.68e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—TH—polycystic ovary syndrome	7.2e-06	7.58e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	7.01e-06	7.37e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	6.59e-06	6.93e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	6.52e-06	6.86e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—POMC—polycystic ovary syndrome	6.43e-06	6.76e-05	CbGpPWpGaD
Mirabegron—ABCB1—Metabolism—INS—polycystic ovary syndrome	6.39e-06	6.73e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	6.14e-06	6.46e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	6.06e-06	6.37e-05	CbGpPWpGaD
Mirabegron—CYP2D6—Metabolism—INS—polycystic ovary syndrome	6.02e-06	6.34e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	5.88e-06	6.19e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	5.6e-06	5.9e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	5.31e-06	5.59e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	4.95e-06	5.21e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	4.02e-06	4.23e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	3.96e-06	4.17e-05	CbGpPWpGaD
Mirabegron—CYP3A4—Metabolism—INS—polycystic ovary syndrome	3.94e-06	4.14e-05	CbGpPWpGaD
